BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 26, 2026
See today's BioWorld Asia
Home
» Other news to note for April 6, 2021
To read the full story,
subscribe
or
sign in
.
Other news to note for April 6, 2021
April 6, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Affamed, Ajinomoto, Anixa, Arbutus, Aspect Biosystems, Astellas Gene Therapies, Bright Peak, Celonic, Chromadex, Claritas, Curevac, Emergent Biosolutions, Frontier, Glaxosmithkline, Gracell, Iconovo, Immune System Regulation, Immuneoncia, Johnson & Johnson, JSR, Lianbio, Novavax, Ontochem, Ovid, Panacea, Proteros Biostructures, Recce, Sifi, Sinovac, Sumitomo Dainippon, Takeda, Tarsus, Telix, Teva, Vir.
BioWorld Asia
Briefs
Other news to note